Hetero's Tocira gets Emergency Use Authorization from DCGI for the generic version of Tocilizumab in India.
<p>
Hyderabad-based pharma company Hetero said on Monday it has received emergency use approval from the Indian health authorities to make a generic version of Swiss giant Roche Holding AG&#39;s drug Tocilizumab used for treating COVID-19 patients.</p>
<p>
Hetero is likely to make the cheaper version of Tocilizumab available in Indian market by the end of the month under the local brand name Tocira. The drug will be produced at the company&rsquo;s plant in Hyderabad.</p>
<p>
Tocilizumab has been in high demand due to the surge in COVID-19 cases and there is a shortage of the drug worldwide.</p>
<p>
Roche&#39;s blockbuster arthritis drug, tocilizumab, cuts the risk of death among patients hospitalised with severe COVID-19. It also cuts the recovery time and reduces the need for mechanical ventilation.</p>
<p>
Hetero, also makes medicines such as remdesivir and favipiravir used for treating COVID-19 patients.</p>
Political activist from Pakistan-occupied Jammu Kashmir (PoJK), Amjad Ayub Mirza, has condemned China's involvement in…
Bhutan Prime Minister Tshering Tobgay has said that he considers Prime Minister Narendra Modi as…
Prime Minister Narendra Modi met the Chief Advisor of the government of Bangladesh, Muhammad Yunus…
The Cabinet Committee on Economic Affairs, chaired by the Prime Minister Narendra Modi, has approved…
Prime Minister Narendra Modi on Friday met with Bangladesh's chief advisor Muhammad Yunus for the…
Ambassador of India to Myanmar, Abhay Thakur said on Friday that under Prime Minister Narendra…